It has often been said that imitation is the ultimate form of flattery. If that is the case, there is no greater flatterer of Warren Buffett than legendary Indian-American investor Monish Pabrai. He has become known in some circles as “the Oracle of Irvine” and just like his hero, the Oracle of Omaha, he has shown an almost clairvoyant ability to produce superior returns. In fact, a $100,000 investment in July 1999 in Pabrai Investment Funds (in fact, minimum investment is $2.5m) would have been worth $1.8m by March 2018. Pabrai is shameless about the fact that he has cloned Buffett’s approach almost to a tee. I will now shamelessly admit that I fully intend to clone his approach and will explain how.
Say no to almost everything
Like Buffett, Pabrai sifts through hundreds of companies at lightning speed. He often does this by reading annual reports and other financial information. Both of them are often looking for a reason to say no. Why? Because the type of company that would justify investment is an extraordinary business and there aren’t too many of those lying around.
I try to search for companies that I believe have a durable competitive advantage in the long term. In other words, companies I believe will be around and thriving in the next 30 years. This is because my investment horizon, like Buffett’s or Pabrai’s, is for life. If I don’t think the business has that type of longevity, I steer clear.
“Heads, I win; tails, I don’t lose much“
This quote by Pabrai encapsulates a simple but profound idea: the price paid for the stock must be at such a large discount to the underlying value of the business that it provides a margin of safety. Simply put, I have become a bargain hunter. This is easier said than done in a world where hype drives some companies to insane valuations but it has been crucial to the success that Buffett and Pabrai have enjoyed. It also means a lot of waiting around because opportunities to buy great businesses for pence on the pound don’t come often.
Extreme concentration
Charlie Munger once said that “a well-diversified portfolio needs just four stocks“. Munger is Buffett’s long-time partner and therefore also a hero of Pabrai’s by association. Pabrai has taken this advice quite literally. In 2015, half of his fund was in just two investments – General Motors and Fiat Chrysler warrants. When Fiat’s stock surged, he made seven times his money in six years.
It’s an extreme example but there’s a lesson here. The idea I’ve implemented from this is to focus on a few very good, intensely researched ideas. Diversification has been used with great effect by great investors such as Ray Dalio. Index funds offer great diversification too. However, when picking individual stocks, I’m searching for just a handful of the absolute best stocks. While I still hold a part of my portfolio in index funds, the part that consists of individual stock picks contains just six painstakingly researched businesses.
The post How I plan to clone the man who cloned Warren Buffett appeared first on The Motley Fool UK.
Is this little-known company the next ‘Monster’ IPO?
Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.
Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.
The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.
But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.
Click here to see how you can get a copy of this report for yourself today
More reading
2 dirt-cheap stocks to buy, including a top FTSE 100 share!
8.5%+ dividend yields! 2 top FTSE 100 shares to buy right now
A FTSE 100 dividend stock with a yield near 5% and new growth potential
My best growth stocks to buy now with £5k
This FTSE 100 share has crashed 42% in a year. Should I buy now?
Stephen Bhasera has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
